{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:53:33Z","timestamp":1790258013671,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T00:00:00Z","timestamp":1550534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81500137"],"award-info":[{"award-number":["81500137"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12881-019-0765-3","type":"journal-article","created":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T05:03:48Z","timestamp":1550552628000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Novel mutations of STXBP2 and LYST associated with adult haemophagocytic lymphohistiocytosis with Epstein-Barr virus infection: a case report"],"prefix":"10.1186","volume":"20","author":[{"given":"Lingshuang","family":"Sheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kefeng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0875-3803","authenticated-orcid":false,"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,19]]},"reference":[{"key":"765_CR1","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/bjh.12293","volume":"161","author":"GN Usmani","year":"2013","unstructured":"Usmani GN, Woda BA. Advances in understanding the pathogenesis of HLH. Br J Haematol. 2013;161:609\u201322.","journal-title":"Br J Haematol"},{"key":"765_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0092-8674(03)00855-9","volume":"115","author":"J Feldmann","year":"2003","unstructured":"Feldmann J, Callebaut I, Raposo G, Certain S, Bacq D, Dumont C, et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell. 2003;115:461\u201373.","journal-title":"Cell."},{"key":"765_CR3","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/hmg\/ddi076","volume":"14","author":"SU Zur","year":"2005","unstructured":"Zur SU, Schmidt S, Kasper B, Beutel K, Diler AS, Henter JI, et al. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet. 2005;14:827\u201334.","journal-title":"Hum Mol Genet"},{"key":"765_CR4","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.ajhg.2009.09.005","volume":"85","author":"SU Zur","year":"2009","unstructured":"Zur SU, Rohr J, Seifert W, Koch F, Grieve S, Pagel J, et al. Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Am J Hum Genet. 2009;85:482\u201392.","journal-title":"Am J Hum Genet"},{"key":"765_CR5","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1126\/science.286.5446.1957","volume":"286","author":"SE Stepp","year":"1999","unstructured":"Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, Mathew PA, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999;286:1957\u20139.","journal-title":"Science."},{"key":"765_CR6","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/cge.12682","volume":"89","author":"JY Seo","year":"2016","unstructured":"Seo JY, Lee KO, Yoo KH, et al. Prevalence of type 5 familial hemophagocytic lymphohistiocytosis in Korea and novel mutations in STXBP2. Clin Genet. 2016;89:222\u20137.","journal-title":"Clin Genet"},{"key":"765_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/MOH.0b013e3282f2bcce","volume":"15","author":"J Kaplan","year":"2008","unstructured":"Kaplan J, De Domenico I. Chediak-Higashi syndrome. Curr Opin Hematol. 2008;15:22\u20139.","journal-title":"Curr Opin Hematol"},{"key":"765_CR8","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.1182\/blood-2011-07-370148","volume":"118","author":"K Zhang","year":"2011","unstructured":"Zhang K, Jordan MB, Marsh RA, et al. Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. Blood. 2011;118:5794\u20138.","journal-title":"Blood."},{"key":"765_CR9","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1002\/pbc.21438","volume":"50","author":"AD Beaty","year":"2008","unstructured":"Beaty AD, Weller C, Levy B, Vogler C, Ferguson WS, Bicknese A, et al. A teenage boy with late onset hemophagocytic lymphohistiocytosis with predominant neurologic disease and perforin deficiency. Pediatr Blood Cancer. 2008;50:1070\u20132.","journal-title":"Pediatr Blood Cancer"},{"key":"765_CR10","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s12185-015-1807-z","volume":"102","author":"L Gao","year":"2015","unstructured":"Gao L, Zhu L, Huang L, Zhou J. Synergistic defects of UNC13D and AP3B1 leading to adult hemophagocytic lymphohistiocytosis. Int J Hematol. 2015;102:488\u201392.","journal-title":"Int J Hematol"},{"key":"765_CR11","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1182\/blood-2014-05-573105","volume":"124","author":"K Zhang","year":"2014","unstructured":"Zhang K, Chandrakasan S, Chapman H, Valencia CA, Husami A, Kissell D, et al. Synergistic defects of different molecules in the cytotoxic pathway lead to clinical familial hemophagocytic lymphohistiocytosis. Blood. 2014;124:1331\u20134.","journal-title":"Blood."},{"key":"765_CR12","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1182\/blood-2015-12-688960","volume":"127","author":"FE Sepulveda","year":"2016","unstructured":"Sepulveda FE, Garrigue A, Maschalidi S, et al. Polygenic mutations in the cytotoxicity pathway increase susceptibility to develop HLH immunopathology in mice. Blood. 2016;127:2113\u201321.","journal-title":"Blood."},{"issue":"2","key":"765_CR13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"J Henter","year":"2007","unstructured":"Henter J, Horne A, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, Mcclain K, Webb D, Winiarski J, Janka G. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124\u201331.","journal-title":"Pediatr Blood Cancer"},{"key":"765_CR14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1084\/jem.20161846","volume":"214","author":"SG Tangye","year":"2017","unstructured":"Tangye SG, Palendira U. Human immunity against EBV-lessons from the clinic. J Exp Med. 2017;214:269\u201383.","journal-title":"J Exp Med"},{"key":"765_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13045-016-0317-7","volume":"9","author":"J Wang","year":"2016","unstructured":"Wang J, Wang Y, Wu L, et al. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Hematol Oncol. 2016;9:84.","journal-title":"J Hematol Oncol"},{"key":"765_CR16","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s10875-015-0201-1","volume":"35","author":"C Picard","year":"2015","unstructured":"Picard C, Al-Herz W, Bousfiha A, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for primary immunodeficiency 2015. J Clin Immunol. 2015;35:696\u2013726.","journal-title":"J Clin Immunol"},{"key":"765_CR17","first-page":"162","volume":"5","author":"W Al-Herz","year":"2014","unstructured":"Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, Cunningham-Rundles C, et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol. 2014;5:162.","journal-title":"Front Immunol"},{"key":"765_CR18","doi-asserted-by":"crossref","unstructured":"Cohen JI. Primary Immunodeficiencies Associated with EBV Disease. Curr Top Microbiol Immunol. 2015;390:241\u2013265.","DOI":"10.1007\/978-3-319-22822-8_10"},{"key":"765_CR19","first-page":"3930750","volume":"2018","author":"B Zhao","year":"2018","unstructured":"Zhao B, Chang L, Fu H, et al. The role of autoimmune regulator (AIRE) in peripheral tolerance. J Immunol Res. 2018;2018:3930750.","journal-title":"J Immunol Res"},{"key":"765_CR20","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.immuni.2018.04.018","volume":"48","author":"NM Adams","year":"2018","unstructured":"Adams NM, Lau CM, Fan X, et al. Transcription Factor IRF8 Orchestrates the Adaptive Natural Killer Cell Response. Immunity. 2018;48:1172\u201382 e6.","journal-title":"Immunity"},{"key":"765_CR21","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0037-1963(03)70004-3","volume":"40","author":"A Yachie","year":"2003","unstructured":"Yachie A, Kanegane H. Epstein-Barr virus-associated T\u2212\/natural killer cell lymphoproliferative diseases. Semin Hematol. 2003;40:124\u201332.","journal-title":"Semin Hematol"},{"key":"765_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00262-001-0246-2","volume":"51","author":"M Hagihara","year":"2002","unstructured":"Hagihara M, Gansuvd B, Ueda Y, et al. Killing activity of human umbilical cord blood-derived TCRValpha24(+) NKT cells against normal and malignant hematological cells in vitro: a comparative study with NK cells or OKT3 activated T lymphocytes or with adult peripheral blood NKT cells. Cancer Immunol Immunother. 2002;51:1\u20138.","journal-title":"Cancer Immunol Immunother"},{"key":"765_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3389\/fimmu.2017.00329","volume":"8","author":"A Sarvaria","year":"2017","unstructured":"Sarvaria A, Jawdat D, Madrigal JA. Umbilical cord blood natural killer cells, their characteristics, and potential clinical applications. Front Immunol. 2017;8:329.","journal-title":"Front Immunol"},{"key":"765_CR24","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/ajh.21236","volume":"83","author":"RL Olin","year":"2008","unstructured":"Olin RL, Nichols KE, Naghashpour M, et al. Successful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosis. Am J Hematol. 2008;83:747\u20139.","journal-title":"Am J Hematol"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-019-0765-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12881-019-0765-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-019-0765-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T19:15:28Z","timestamp":1582053328000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/s12881-019-0765-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,19]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["765"],"URL":"https:\/\/doi.org\/10.1186\/s12881-019-0765-3","relation":{},"ISSN":["1471-2350"],"issn-type":[{"value":"1471-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,19]]},"assertion":[{"value":"19 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The publication of this manuscript has been reviewed and approved by the Tongji Hospital, Tongji Medical College, and Huazhong University of Science and Technology institutional review board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient and her family have provided written consent for the publication of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"34"}}